Skip to main content

National Cancer Institute — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

102
Companies
$325.9M
Total invested
$3.4M
Avg. check
23
Industries
Biotechnology 17Health Care 10Medical 9Life Science 6Therapeutics 5Medical Device 4+17 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 102
Tiga TX
December 2024

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

Biotechnology · Boston$35.5M Grant
Polygon Health Analytics
November 2024

We help healthcare and life sciences organizations to accelerate evidence-based decisions using real-world data, AI, and outcomes research.

Analytics · Philadelphia$296K Grant
Previse
October 2024

Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.

Biotechnology · Baltimore$1.8M Grant
Palm Therapeutics
September 2024

Palm Therapeutics is a next-generation therapeutics company to cure cancer at its source.

Biotechnology · San Diego$250K Grant
Ananya Health
September 2024

Ananya Health develops a medical device for treating cervical pre-cancer.

Health Care · San FranciscoGrant
Voximetry
August 2024

Voximetry is a healthtech software company that aims to give many cancer patients an alternative to chemotherapy.

Biotechnology · Madison$2.0M Grant
Matter Bio
May 2024

Matter Bio operates as company focus on preserving genome integrity.

Biotechnology · New YorkGrant
Microvascular Therapeutics
October 2023

Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.

Biotechnology · Tucson$4.0M Grant
Modifi Bio
October 2023

Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.

Biotechnology · New Haven$4.3M Seed
Saros Therapeutics
September 2023

Saros Therapeutics is working to enhance patients' response to immunotherapy.

Biotechnology · Chicago$2.0M Grant
Current Surgical
August 2023

Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.

Health Care · WashingtonNon-equity Assistance
Histolix
June 2023

Histolix provides an intrinsically digital and slide-free histopathology solution.

Image Recognition · Sacramento$3.2M Grant
Helocyte
June 2023

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.

Biotechnology · New York$3.2M Grant
Reveal Pharmaceuticals
May 2023

Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.

Biotechnology · Cambridge$500K Grant
Georgia Cancer Center
April 2023

Georgia Cancer Center provides industry-leading cancer research and care that benefits patients locally and globally.

Health Care · Augusta$2.3M Grant
Isabl Inc.
April 2023

Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.

Biotechnology · New York$2.0M Grant
GigaMune
March 2023

GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.

Biotechnology · San FranciscoSeed
Clara Biotech
January 2023

We are exosomes! We can extract any species of pure, viable, in-tact exosome from any biofluid source into pure solution.

Biotechnology · LawrenceNon-equity Assistance
OnLume
January 2023

OnLume provides intuitive and ergonomic solutions for the integration of precise fluorescence image-guided surgery.

Health Care · Madison$2.8M Venture - Series Unknown
Kovina Therapeutics
November 2022

Kovina Therapeutics operates as a pre-clinical biotechnology company.

Biotechnology · Indianapolis$275K Grant
Monon Bioventures
September 2022

Monon Bioventures is a privately held company created to assist world-class investigators

Biotechnology · Fishers$398K Grant
Oleolive
September 2022

Olive Oil is a biotechnology company that produces extra virgin olive oil.

Biotechnology · Shreveport$400K Grant
Telehealth ReseArch Center of Excellence
August 2022

Telehealth Research Center of Excellence is a cancer center that is engaged in improving cancer-related care and outcomes.

Education · Philadelphia$5.7M Grant
AUM LifeTech
August 2022

AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.

Biotechnology · Philadelphia$400K Grant

Where National Cancer Institute invests

Biotechnology17
Health Care10
Medical9
Life Science6
Therapeutics5
Medical Device4

About National Cancer Institute's portfolio

How many companies has National Cancer Institute invested in?▸

National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Cancer Institute invest in?▸

National Cancer Institute's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 23 different industry categories.

What is National Cancer Institute's largest investment?▸

Among tracked funding rounds, Tiga TX received $35.5M in a Grant round. National Cancer Institute's total known invested capital is $325.9M.

What is the average investment size for National Cancer Institute?▸

National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.

What are National Cancer Institute's most recent investments?▸

Recent National Cancer Institute portfolio additions include Tiga TX, Polygon Health Analytics, Previse, Palm Therapeutics, Ananya Health. These companies were founded in 2020 or later.

Reach the founders behind these 102 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →